Who is sponsoring NCT02446548?

NCT02446548 is sponsored by Medical University of Gdansk.

What condition does NCT02446548 study?

NCT02446548 studies Albuminuria.

What drugs are being tested in NCT02446548?

Interventions: aliskiren, losartan, Placebo.

What is the status of NCT02446548?

NCT02446548 is currently COMPLETED.

Last reviewed 2015-05-13 · How we verify

Influence of Aliskiren on Albuminuria After Kidney Transplantation

NCT02446548 NA COMPLETED

The study is a randomised, double-blind, controlled 2 x 3 cross-over trial in which the renal effects of therapy with aliskiren (A), placebo (P) and losartan (L) will be compared. It consists of an 8-week run-in period, 8 weeks of active treatment with aliskiren or losartan (period 1), 8 weeks of active treatment with the alternative medication (period 2), and an 8-week placebo administration between them.

Details

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	COMPLETED
Enrolment	18
Start date	2013-03
Completion	2014-11

Conditions

Albuminuria

Interventions

aliskiren
losartan
Placebo

Primary outcomes

a difference in albuminuria in the measurements available for each patient — after 8 weeks of treatment

Countries

Poland